Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

The 2013 Audi Q3 2.0 TFSI quattro is the Armani suit in the popular small-SUV market segment, offering smart modern styling, German technical expertise, and lots of class and prestige. It is ...